Trials / Completed
CompletedNCT01346891
Polymorphisms of the Thiazide's Receptor Gene SLC12A3 and Development of Hyponatremia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Hospital Italiano de Buenos Aires · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to detect if there are any differences in the coding region of SLC12A3 gene in individuals who have had hyponatremia associated to the use of thiazides, and those thiazides consumers without hyponatremia that have demonstrated good tolerance to the drug.
Detailed description
This is a Case Control study to compare the coding region of SLC12A3 gene in individuals who have had hyponatremia associated to the use of thiazides, and those thiazides consumers without hyponatremia that have demonstrated good tolerance to the drug.
Conditions
Timeline
- Start date
- 2010-07-01
- First posted
- 2011-05-03
- Last updated
- 2011-07-06
Locations
1 site across 1 country: Argentina
Source: ClinicalTrials.gov record NCT01346891. Inclusion in this directory is not an endorsement.